Anti-Human MSLN Monoclonal Antibody (1A585)
Anti-Human MSLN Monoclonal Antibody (1A585) is a highly specific and reliable tool for targeting mesothelin (MSLN) in human cells. This monoclonal antibody is produced using advanced technology and has been extensively tested to ensure its high quality and consistency.
Biological Function
MSLN is a glycosylphosphatidylinositol-anchored cell surface glycoprotein that is overexpressed in various types of cancer, including mesothelioma, ovarian cancer, and pancreatic cancer. It plays a critical role in cancer progression and is considered a promising target for cancer therapy.
Main Applications
The Anti-Human MSLN Monoclonal Antibody (1A585) is specifically designed for use in various applications, including Western blotting, immunohistochemistry, and flow cytometry. It has been validated for use in human samples and has shown high sensitivity and specificity in detecting MSLN expression in cancer cells.
Experimental Use Cases
This antibody has been successfully used in a variety of experimental studies to investigate the role of MSLN in cancer. It has been used to study the expression of MSLN in different cancer cell lines and tissues, as well as in patient samples. It has also been used in functional studies to understand the role of MSLN in cancer cell proliferation, migration, and invasion.
With its high specificity and sensitivity, the Anti-Human MSLN Monoclonal Antibody (1A585) is an essential tool for researchers studying MSLN and its potential as a therapeutic target in cancer. Its reliable performance and consistent results make it a valuable addition to any research project.
In conclusion, the Anti-Human MSLN Monoclonal Antibody (1A585) is a highly specific and reliable tool for targeting MSLN in human cells. Its advanced technology, extensive testing, and validated applications make it an essential choice for researchers studying the role of MSLN in cancer. Add it to your research arsenal today and unlock the potential of MSLN as a therapeutic target.
There are no reviews yet.